This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2018
  • /
  • 09
  • /
  • Taking Diabetes to Heart survey is presented by In...
Drug news

Taking Diabetes to Heart survey is presented by International Diabetes Federation and Novo Nordisk.

Read time: 1 mins
Last updated:29th Sep 2018
Published:29th Sep 2018
Source: Pharmawand

Commenting on the findings, IDF President Professor Nam H. Cho said: "These survey findings confirm our concerns about the increasing global prevalence of diabetes and its associated complications. Awareness of the risks and consequences of the disease remains pitifully low and education to address diabetes complications is lacking. We urge governments to invest in measures to detect type 2 diabetes early and ensure that health professionals are trained to guide people to make positive changes to their lifestyle and better manage their diabetes. This will help people to avoid disabling and life-threating diabetes complications."

Diabetes currently affects 425 million adults worldwide, with most cases being type 2 diabetes. CVD, which includes stroke, coronary heart disease and peripheral artery disease,4 is the leading cause of disability and death in people with type 2 diabetes. In the Taking Diabetes to Heart survey, 3 in 4 people with type 2 diabetes said they relied on information about CVD from their doctor. More than half of respondents said they needed more information about the risk factors associated with the development of CVD to better understand the risks in order to help prevent them.

"Cardiovascular disease can have a devastating impact on the lives of people with type 2 diabetes and their families," said Professor Stephen Gough, global chief medical officer of Novo Nordisk. "The IDF survey findings are striking and reinforce the importance of raising awareness of CVD risk and its impact on people living with type 2 diabetes. We are committed to continue working with IDF while utilising these global findings to inform future efforts that can help improve health outcomes."

Taking Diabetes to Heart will culminate in a comprehensive report with regional and country-specific results and resources to help support knowledge and awareness of CVD among people with type 2 diabetes and those at risk around the world.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.